Evidence map›Paper›PMID 22575403›Full record

ReviewJournal of the neurological sciences2012

Vascular dementia.

Amos D Korczyn, Veronika Vakhapova, Lea T Grinberg

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of the neurological sciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06321380 (Efficacy of Working Memory Maintenance Mechanisms in Alzheimer's Disease and Vascular Dementia), which is not on this map. Cited by 64 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 3 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06321380 unknown statusnot on this mapstarted 2024, after this paper: background citation

Efficacy of Working Memory Maintenance Mechanisms in Alzheimer's Disease and Vascular Dementia

Typeobservational_patient_registrySponsorUniversity Hospital, GrenobleRan2024 to 2025Enrolled120ConditionsAlzheimer Disease, Vascular Dementia, Mixed DementiasArmsComplex span task, Clinical neuropsychological assessment, Clinical neurospychological assessement
3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 3 syntheses or guidelines pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Cerebrolysin for vascular dementia.The Cochrane database of systematic reviews · 2019
    Pooled it
  4. Trial
  5. Review
  6. Effects of Gelatin Hydrolysate from Bigeye Snapper (International journal of molecular sciences · 2026
    Article
  7. Article
  8. Article
  9. Cerebrovascular remodeling in aging and neurodegenerative disease progression.Frontiers in bioengineering and biotechnology · 2025
    Article
  10. Article
  11. Article
  12. Sulfur-bridging the gap: investigating the electrochemistry of novel copper chelating agents for Alzheimer's disease applications.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Amos D KorczynSackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel.
Veronika Vakhapova
Lea T Grinberg
Maccabi Health Care Services · ILTel Aviv University · ILUniversity of California, San Francisco · US

Funding

PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, YADONG · 2004 to 2018
$27.1M
Brainstem as an early site in AD and FTLD: closing the etiopathogenic gapR01AG040311 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRINBERG, LEA TENENHOLZ · 2011 to 2015
$2.0M
NIA NIH HHS P50 AG023501NIA NIH HHS R01 AG040311
6 · The paper itself

Abstract

The epidemic growth of dementia causes great concern for the society. It is customary to consider Alzheimer's disease (AD) as the most common cause of dementia, followed by vascular dementia (VaD). This dichotomous view of a neurodegenerative disease as opposed to brain damage caused by extrinsic factors led to separate lines of research in these two entities. Indeed, accumulated data suggest that the two disorders have additive effects and probably interact; however it is still unknown to what degree. Furthermore, epidemiological studies have shown "vascular" risk factors to be associated with AD. Therefore, a clear distinction between AD and VaD cannot be made in most cases, and is furthermore unhelpful. In the absence of efficacious treatment for the neurodegenerative process, special attention must be given to the vascular component, even in patients with presumed mixed pathology. Symptomatic treatment of VaD and AD is similar, although the former is less effective. For prevention of dementia it is important to treat all factors aggressively, even in stroke survivors who do not show evidence of cognitive decline. In this review, we will give a clinical and pathological picture of the processes leading to VaD and discuss its interaction with AD.

Indexed as

Dementia, VascularAnimalsCognition DisordersHumansRisk Factors

Identifiers

PMID22575403
PMCPMC3435447
OpenAlexW4211241499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.